Predictors for achieving, sustaining blood glucose control, weight loss with tirzepatide in adults with type 2 diabetes
The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine (a long-acting insulin) for type 2 diabetes (T2D). Now new research examining ...
9 hours ago
0
1